Chairs

  • Emily Breidbart
  • Sowmya Krishnan

BOD Liaison

Laurie Cohen

Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.

Drug Alerts/Recalls – TIROSINT®-SOL
February 9, 2023

IBSA Pharma Inc. has announced a voluntary recall of 27…

New Drugs and Therapeutics Update TZIELDTM (teplizumab-mzwv)
December 16, 2022

On November 17, 2022, the FDA announced the approval of…

FDA notice on sitagliptin contamination
November 9, 2022

FDA notice on sitagliptin contamination The Food and Drug Administration…